Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1216Urinary Bladder Neoplasms 387Carcinoma, Renal Cell 329Kidney Neoplasms 205Neoplasms 157Breast Neoplasms 146Lung Neoplasms 101Carcinoma, Transitional Cell 100Colorectal Neoplasms 77Testicular Neoplasms 74Ovarian Neoplasms 62Melanoma 60Pancreatic Neoplasms 57Colonic Neoplasms 50Carcinoma, Non-Small-Cell Lung 50Head and Neck Neoplasms 47Disease 47Stomach Neoplasms 45Non-Muscle Invasive Bladder Neoplasms 45Neoplasm Metastasis 41Liver Neoplasms 40Uterine Cervical Neoplasms 39Esophageal Neoplasms 37Wilms Tumor 36Prostatic Hyperplasia 36Adenocarcinoma 33Multiple Myeloma 32Urologic Neoplasms 30Sarcoma 30Recurrence 30

Interventions

radium Ra 223 dichloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Metastatic Castration Resistant Prostate Cancer (mCRPC) × Genitourinary × Clear all
NCT05208229 2025-04-01

WB-LuPSMA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Terminated
2 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT04516161 2022-03-31

EPIX

Bayer

Completed
1,180 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡